Drug discovery for leishmaniasis

📁 Drug discovery for leishmaniasis

✍ Luis Rivas, Luis Rivas, Carmen Gil, Carmen Gil, David Thurston, Ana Martinez, Ph 📂 Library 📅 2018 🏛 Royal Society of Chemistry 🌐 English

For human health, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Globally, 10 to 12 million people are infected with 1.5 million new cases every year. The development of cheaper new drugs is urgently needed for this neglected disease that is developing r

Leishmania and Leishmaniasis

📁 Leishmania and Leishmaniasis

✍ Awanish Kumar (auth.) 📂 Library 📅 2013 🏛 Springer-Verlag New York 🌐 English

Leishmania-related illnesses remain among the world’s deadliest neglected tropical diseases, affecting approximately 12 million people in 88 countries. The mortality rate is substantial, contributing to nearly two million disability-adjusted life years. As more is understood about this parasite

Chemoinformatics for Drug Discovery

📁 Chemoinformatics for Drug Discovery

✍ Jürgen Bajorath 📂 Library 📅 2013 🏛 Wiley 🌐 English

Chemoinformatics strategies to improve drug discovery resultsWith contributions from leading researchers in academia and the pharmaceutical industry as well as experts from the software industry, this book explains how chemoinformatics enhances drug discovery and pharmaceutical rese

Drug Discovery for Schizophrenia

📁 Drug Discovery for Schizophrenia

✍ Tatiana V Lipina, Tatiana V Lipina, John C Roder, David Thurston, Ana Martinez, 📂 Library 📅 2015 🏛 Royal Society of Chemistry 44 🌐 English

Since the pioneering pharmacotherapy for treatment of schizophrenia in the 1950s by antipsychotics, only a few major innovations have been made, pointing to a general stagnation in the field of pharmacology of schizophrenia. Drug Discovery for Schizophrenia covers new insights in th

Drug Discovery for Schizophrenia

📁 Drug Discovery for Schizophrenia

✍ Tatiana V Lipina, Tatiana V Lipina, John C Roder, David Thurston, Ana Martinez, 📂 Library 📅 2015 🏛 Royal Society of Chemistry 🌐 English

Since the pioneering pharmacotherapy for treatment of schizophrenia in the 1950s by antipsychotics, only a few major innovations have been made, pointing to a general stagnation in the field of pharmacology of schizophrenia. Drug Discovery for Schizophrenia covers new insights in th

Epigenetics for Drug Discovery

📁 Epigenetics for Drug Discovery

✍ Nessa Carey (ed.) 📂 Library 📅 2015 🏛 National Book Network International,Royal Society 🌐 English

Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company and a substantial number of biotechnology companies targeting epigenetic processes to treat diseases ranging from cancer to Huntington’s disease and from inflammation to sickle cell a

Drug discovery for leishmaniasis

✦ Subjects